---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-245651"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2022-09-15T23:59:59+00:00"
generated_at: "2026-06-23T09:19:09.708174+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# MEI Pharma Chair Christine White to retire, not stand for reelection; board size to reduce to eight

## Summary
- Dr. Christine A. White, Board Chair, will retire and not stand for reelection at fiscal 2023 annual meeting, ending 12+ years of service.
- White will continue as Chair and director until the annual meeting; retirement not due to any disagreement with the company.
- Board does not plan to appoint a new director; board size will decrease from nine to eight directors.
- Successor Chair is under consideration but no formal decision has been made as of the filing date.

## SEC filing metadata
- accession: 0001193125-22-245651
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2022-09-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000119312522245651/0001193125-22-245651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000119312522245651/d399392d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-245651
- JSON: https://secwatch.observer/filing/0001193125-22-245651.json
- Plain text: https://secwatch.observer/filing/0001193125-22-245651.txt

## Key facts
- Executive change
  Dr. Christine A. White departed as Chair and member of the Board of Directors at Lite Strategy, Inc..
  - Action: retire and not stand for reelection
  - Role: Chair and member of the Board of Directors
  source text: Dr. Christine A. White, Chair and member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) and member of the Nominating and Corporate Governance Committee of the Board (the “Committee”), informed the Company that, after more than 12 years of service, she has decided to formally retire and thus she does not intend to stand for reelection at the Company’s fiscal year 2023 annual meeting of stockholders (the “Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1262104/000119312522245651/0001193125-22-245651-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.